{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:46Z","timestamp":1790885566594,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Yuzuncu Yil University","award":["2015-TF-U040"],"award-info":[{"award-number":["2015-TF-U040"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.07.125","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T13:10:34Z","timestamp":1532956234000},"page":"1705-1712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicity"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-1715","authenticated-orcid":false,"given":"Kaan","family":"Demiroren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Turan","family":"Basunlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remzi","family":"Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Cokluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.07.125_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0010","first-page":"185","article-title":"Postulated carbon tetra-chloride mode of action: a review","volume":"25","author":"Manibusan","year":"2007","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.biopha.2018.07.125_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.phrs.2015.03.011","article-title":"Thymoquinone and its therapeutic potentials","volume":"95-96","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2018.07.125_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2015.06.023","article-title":"Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review","volume":"28","author":"Majdalawieh","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0025","first-page":"9","article-title":"Gastrointestinal effects of Nigella sativa and its main constituent, thymoquinone: a review","volume":"6","author":"Shakeri","year":"2016","journal-title":"Avicenna J. Phytomed."},{"issue":"2","key":"10.1016\/j.biopha.2018.07.125_bib0030","first-page":"22","article-title":"Silymarin\/silybin and chronic liver disease: a marriage of many years","volume":"24","author":"Federico","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2018.07.125_bib0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"20","author":"Surai","year":"2015","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.biopha.2018.07.125_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clinre.2013.08.014","article-title":"Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis","volume":"38","author":"Demiroren","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"80","key":"10.1016\/j.biopha.2018.07.125_bib0050","first-page":"265","article-title":"N-acetylcysteine: multiple clinical applications","volume":"1","author":"Millea","year":"2009","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.biopha.2018.07.125_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0003-2697(86)90061-8","article-title":"Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman\u2019s reagent","volume":"153","author":"Eyer","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2018.07.125_bib0060","doi-asserted-by":"crossref","first-page":"36381","DOI":"10.1155\/2007\/36381","article-title":"Protective role of genistein inacute liver damage induced by carbon tetrachloride","volume":"2007","author":"Kuzu","year":"2007","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2018.07.125_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10753-007-9053-z","article-title":"The treatment with antibody of TNF-alpha reducesthe inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine and choline-deficient diet","volume":"31","author":"Koca","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2018.07.125_bib0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S0004-28032008000200013","article-title":"Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats","volume":"45","author":"Pereira-Filho","year":"2008","journal-title":"Arq. Gastroenterol."},{"issue":"262","key":"10.1016\/j.biopha.2018.07.125_bib0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.toxlet.2016.09.014","article-title":"Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury","volume":"16","author":"Yang","year":"2016","journal-title":"Toxicol. Lett."},{"issue":"14","key":"10.1016\/j.biopha.2018.07.125_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12967-016-1040-4","article-title":"The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats","volume":"29","author":"Abdelghany","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.07.125_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biochi.2016.05.020","article-title":"Thymoquinone, an active constituent of Nigella sativa seeds, binds with bilirubin and protects mice from hyperbilirubinemia and cyclophosphamide-induced hepatotoxicity","volume":"127","author":"Laskar","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2018.07.125_bib0090","first-page":"823","article-title":"Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress, inflammation and apoptosis","volume":"65","author":"Galaly","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0095","doi-asserted-by":"crossref","first-page":"12206","DOI":"10.1007\/s11356-016-6419-5","article-title":"Protective effect of thymoquinone against lead-induced hepatic toxicity in rats","volume":"23","author":"Mabrouk","year":"2016","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"14","key":"10.1016\/j.biopha.2018.07.125_bib0100","doi-asserted-by":"crossref","first-page":"12247","DOI":"10.4238\/2015.October.9.13","article-title":"Protective effect of thymoquinone on cholestatic rats with liver injury","volume":"9","author":"Kong","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.biopha.2018.07.125_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/859383","article-title":"Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats","volume":"2015","author":"El-Sheikh","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"14","key":"10.1016\/j.biopha.2018.07.125_bib0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1472-6882-14-282","article-title":"Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-\u03b2","volume":"3","author":"Al-Malki","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2018.07.125_bib0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.intimp.2014.02.006","article-title":"Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice","volume":"19","author":"Bai","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.etap.2013.07.010","article-title":"Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage","volume":"36","author":"Jaswal","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.intimp.2012.12.020","article-title":"Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells","volume":"15","author":"Bai","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.07.125_bib0130","doi-asserted-by":"crossref","first-page":"32610","DOI":"10.18632\/oncotarget.5362","article-title":"TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling","volume":"20","author":"Ke","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.07.125_bib0135","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/or.2014.3059","article-title":"Thymoquinone induces G2\/M arrest, inactivates PI3K\/Akt and nuclear factor-\u03baB pathways in human cholangiocarcinomas both in vitro and in vivo","volume":"31","author":"Xu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.07.125_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11010-013-1930-1","article-title":"Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis","volume":"389","author":"Ashour","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"223","key":"10.1016\/j.biopha.2018.07.125_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.toxlet.2013.08.018","article-title":"Thymoquinone inhibits cell proliferation through regulation of G1\/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma","volume":"23","author":"Raghunandhakumar","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2018.07.125_bib0150","unstructured":"https:\/\/www.sigmaaldrich.com\/MSDS\/MSDS\/DisplayMSDSPage.do?country=TR&language=EN-generic&productNumber=274666&brand=ALDRICH&PageToGoToURL=https%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct%2Faldrich%2F274666%3Flang%3Den (Accessed 15.06.2018)."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2018.07.125_bib0155","first-page":"S337","article-title":"Protective effects of silymarin, alone or in combination with chlorogenic acid and\/or melatonin, against carbon tetrachloride-induced hepatotoxicity","volume":"12","author":"Al-Rasheed","year":"2016","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.biopha.2018.07.125_bib0160","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jmf.2013.0179","article-title":"Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl\u2084-treated rats","volume":"18","author":"Clichici","year":"2015","journal-title":"J. Med. Food"},{"key":"10.1016\/j.biopha.2018.07.125_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopha.2016.03.042","article-title":"Silymarin-loaded Eudragit(\u00ae) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats","volume":"81","author":"Younis","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.07.125_bib0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1684\/ecn.2013.0341","article-title":"Antioxidant, anti-inflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite","volume":"24","author":"Sherif","year":"2013","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.biopha.2018.07.125_bib0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0748233713502841","article-title":"Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice","volume":"32","author":"Bektur","year":"2016","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.biopha.2018.07.125_bib0180","first-page":"190","article-title":"Hepatoprotective property of oral silymarin is comparable to N-Acetyl cysteine in acetaminophen poisoning","volume":"5","author":"Kazemifar","year":"2012","journal-title":"Gastroenterology Res."},{"key":"10.1016\/j.biopha.2018.07.125_bib0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1665-2681(19)31570-4","article-title":"Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats","volume":"10","author":"Ahmed","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0190","article-title":"In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4","volume":"13","author":"Gonz\u00e1lez","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"245","key":"10.1016\/j.biopha.2018.07.125_bib0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.taap.2010.02.002","article-title":"Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver","volume":"1","author":"Patel","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0200","first-page":"633","article-title":"Silybin nanoparticles for liver cancer: development, optimization and in vitro - in vivo evaluation","volume":"21","author":"Zhang","year":"2016","journal-title":"J. BUON"},{"issue":"22","key":"10.1016\/j.biopha.2018.07.125_bib0205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.phymed.2015.05.053","article-title":"Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells","volume":"15","author":"Hsiang","year":"2015","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.biopha.2018.07.125_bib0210","article-title":"Protective role of silymarin on hepatic and renal toxicity induced by MTX based chemotherapy in children with acute lymphoblastic leukemia","volume":"1","author":"Hagag","year":"2016","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"15","key":"10.1016\/j.biopha.2018.07.125_bib0215","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-015-0861-7","article-title":"A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury","volume":"23","author":"Luangchosiri","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2018.07.125_bib0220","first-page":"247","article-title":"Evaluation of hepatoprotective effect of silymarin among under treatment tuberculosis patients: a randomized clinical trial","volume":"15","author":"Marjani","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.biopha.2018.07.125_bib0225","first-page":"1","article-title":"Effect of Liverubin\u2122 on hepatic biochemical profile in patients of alcoholic liver disease: a retrospective study","volume":"105","author":"Nanda","year":"2014","journal-title":"Minerva Med."},{"key":"10.1016\/j.biopha.2018.07.125_bib0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3851\/IMP2806","article-title":"Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy","volume":"20","author":"Canini","year":"2015","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.07.125_bib0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4254\/wjh.v5.i3.109","article-title":"Silymarin in nonalcoholic fatty liver disease","volume":"27","author":"Cacciapuoti","year":"2013","journal-title":"World J. Hepatol."},{"issue":"308","key":"10.1016\/j.biopha.2018.07.125_bib0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2012.8265","article-title":"Silymarin in NASH and C Hepatitis (SyNCH) Study Group. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial","volume":"18","author":"Fried","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2018.07.125_bib0245","unstructured":"https:\/\/www.sigmaaldrich.com\/MSDS\/MSDS\/DisplayMSDSPage.do?country=TR&language=EN-generic&productNumber=S0292&brand=SIGMA&PageToGoToURL=https%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct%2Fsigma%2Fs0292%3Flang%3Den (Accessed 15.06.2018)."},{"key":"10.1016\/j.biopha.2018.07.125_bib0250","series-title":"Toxicology Data Network of U.S. National Library of Medicine","year":"2018"},{"issue":"80","key":"10.1016\/j.biopha.2018.07.125_bib0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainresbull.2009.04.009","article-title":"Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by carbon tetrachloride is reversed by antioxidants","volume":"28","author":"Boer","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2018.07.125_bib0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1382-6689(03)00045-0","article-title":"Protective effects of N-acetylcysteine against carbon tetrachloride- and trichloroethylene-induced poisoning in rats","volume":"14","author":"Wong","year":"2003","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0265","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/01.CCM.0000142699.54266.D9","article-title":"Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats","volume":"32","author":"Ritter","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2018.07.125_bib0270","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","article-title":"N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress","volume":"21","author":"Galicia-Moreno","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"107","key":"10.1016\/j.biopha.2018.07.125_bib0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lfs.2014.04.033","article-title":"Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats","volume":"27","author":"Lasram","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.07.125_bib0280","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10620-012-2512-x","article-title":"Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure","volume":"58","author":"Singh","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2018.07.125_bib0285","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.07.125_bib0290","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hpb.12005","article-title":"N-acetylcysteine administration does not improve patient outcome after liver resection","volume":"15","author":"Robinson","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.biopha.2018.07.125_bib0295","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4038\/cmj.v58i2.5684","article-title":"N-acetylcysteine in children with acute liver failure complicating dengue viral infection","volume":"58","author":"Senanayake","year":"2013","journal-title":"Ceylon Med. J."},{"key":"10.1016\/j.biopha.2018.07.125_bib0300","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/liv.12214","article-title":"Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival","volume":"33","author":"Stravitz","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2018.07.125_bib0305","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1665-2681(19)31749-1","article-title":"Early treatment with N-acetylcysteine in children with acute liver failure secondary to hepatitis A","volume":"8","author":"Sotelo","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2018.07.125_bib0310","unstructured":"https:\/\/www.sigmaaldrich.com\/MSDS\/MSDS\/DisplayMSDSPage.do?country=TR&language=EN-generic&productNumber=PHR1098&brand=SIAL&PageToGoToURL=https%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fsearch%3Fterm%3DN-Acetylcysteine%26interface%3DAll%26N%3D0%26mode%3Dmatch%2520partialmax%26lang%3Den%26region%3DTR%26focus%3Dproduct (Accessed 15.06.2018)."},{"key":"10.1016\/j.biopha.2018.07.125_bib0315","series-title":"Toxicology Data Network of U.S. National Library of Medicine","year":"2018"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218313878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:51:27Z","timestamp":1762311087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218313878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":63,"alternative-id":["S0753332218313878"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.125","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}